Sep. 8, 2023
A DCAF1 Ligand Designed for Targeted Protein Degradation
compound 13
DCAF1 binder preclinical, applied to targeted protein degradation from HTS + optimization ACS Med. Chem. Lett. June 2, 2023 Novartis, Basel, CH
DCAF1 binder preclinical, applied to targeted protein degradation from HTS + optimization ACS Med. Chem. Lett. June 2, 2023 Novartis, Basel, CH